Recently, several pieces of experimental studies including ours demonstrated that intervention of IL-1 signaling mitigates the Tet2 mutation–induced aberrant hematopoiesis and associated chronic inflammation (i.e., chronic colitis) (40Preprint, 52, 53). Here, TET2 is linked to inflammation.